Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines.

about

Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines.

Item

http://www.wikidata.org/entity/Q51742073

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Development of a non-human pri ...... ndidate tuberculosis vaccines.

@en

Development of a non-human pri ...... ndidate tuberculosis vaccines.

@nl

type

Item

label

Development of a non-human pri ...... ndidate tuberculosis vaccines.

@en

Development of a non-human pri ...... ndidate tuberculosis vaccines.

@nl

prefLabel

Development of a non-human pri ...... ndidate tuberculosis vaccines.

@en

Development of a non-human pri ...... ndidate tuberculosis vaccines.

@nl

P1476

Development of a non-human pri ...... ndidate tuberculosis vaccines.

@en

P2093

Ali Hamidi

http://www.w3.org/2001/XMLSchema#string

Andrew White

http://www.w3.org/2001/XMLSchema#string

Charlotte Sarfas

http://www.w3.org/2001/XMLSchema#string

Iman Satti

http://www.w3.org/2001/XMLSchema#string

Joel Meyer

http://www.w3.org/2001/XMLSchema#string

Jonathan Peter

http://www.w3.org/2001/XMLSchema#string

Laura Sibley

http://www.w3.org/2001/XMLSchema#string

Lisa Stockdale

http://www.w3.org/2001/XMLSchema#string

Matthew K O'Shea

http://www.w3.org/2001/XMLSchema#string

Mike J Dennis

http://www.w3.org/2001/XMLSchema#string

P2860

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa

Monkey models of tuberculosis: lessons learned

A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing

Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy.

MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques.

Divergent effect of bacillus Calmette-Guérin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research.

Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature.

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.

P304

99-105

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.TUBE.2017.11.006

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Helen McShane

P577

2017-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29523335

http://www.w3.org/2001/XMLSchema#string

P932

5854371

http://www.w3.org/2001/XMLSchema#string